Investing
Bayer faces class action suit over Monsanto takeover in Germany, law firm says
Published by maria gbaf
Posted on December 16, 2021
2 min readLast updated: January 28, 2026
Quick Summary
Bayer is sued in Germany over its Monsanto acquisition, with investors alleging deception about economic risks. The lawsuit exceeds one billion euros.
Bayer Hit with Class Action Lawsuit Over Monsanto Acquisition
BERLIN (Reuters) – Bayer faces a billion-dollar investor class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto, specialist law firm Tilp Rechtsanwaltsgesellschaft said on Wednesday.
Tilp said it was representing more than 250 institutional investors and a large number of private investors who believed Bayer misled them about the economic risks of the $63 billion acquisition and are demanding damages.
The value of the lawsuits amounts to more than one billion euros ($1.13 billion), the law firm said.
Tilp said it believed Bayer deceived shareholders about the risks of consumer lawsuits pending in the United States linked to the glyphosate-containing weed killer Roundup, which was brought into the company with the 2016 Monsanto acquisition.
Bayer said any complaints were unfounded.
“Bayer has complied with the law and with its disclosure requirements,” the group said. “We will therefore defend ourselves.”
In the United States, Bayer is defending itself against thousands of lawsuits by Roundup users because of the alleged carcinogenic effect of the drug. Bayer has always rejected this.
($1 = 0.8884 euros)
(Reporting by Sabine Wollrab, Patricia Weiss, Matthias Inverardi, Jan Schwartz; Writing by Madeline Chambers; editing by Barbara Lewis)
Key Takeaways
- •Bayer faces a class action lawsuit in Germany.
- •Investors claim they were misled about Monsanto acquisition risks.
- •The lawsuit value exceeds one billion euros.
- •Bayer denies allegations and plans to defend itself.
- •Roundup lawsuits are central to investor concerns.
Frequently Asked Questions about Bayer faces class action suit over Monsanto takeover in Germany, law firm says
1What is the main topic?
The main topic is Bayer facing a class action lawsuit in Germany over its acquisition of Monsanto, with investors alleging they were misled about the risks.
2Why are investors suing Bayer?
Investors claim Bayer misled them about the economic risks associated with the Monsanto acquisition, particularly concerning Roundup lawsuits.
3What is Bayer's response to the lawsuit?
Bayer denies the allegations, stating it has complied with the law and disclosure requirements, and intends to defend itself.
